Sevoflurane
Sevoflurane, USP Volatile Liquid for Inhalation
Approved
Approval ID
ea8bf997-2c71-4014-b18d-4f7ab45dfa19
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 31, 2023
Manufacturers
FDA
Baxter Healthcare Corporation
DUNS: 005083209
FDA
Baxter Healthcare Company
DUNS: 005083209
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sevoflurane
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10019-651
Application NumberANDA075895
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sevoflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 31, 2023
FDA Product Classification
INGREDIENTS (1)
SEVOFLURANEActive
Quantity: 250 mL in 250 mL
Code: 38LVP0K73A
Classification: ACTIB
Sevoflurane
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10019-655
Application NumberANDA075895
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sevoflurane
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 31, 2023
FDA Product Classification
INGREDIENTS (1)
SEVOFLURANEActive
Quantity: 250 mL in 250 mL
Code: 38LVP0K73A
Classification: ACTIB